Search research articles
Contact Us
Filters
Showing results (821-830 of 915) with videos related to
Page
of 92
Sort By:
Journal of Medicinal Chemistry
|
December 23, 1994
Structural evolution and pharmacology of a novel series of triacid angiotensin II receptor antagonists
A D Palkowitz, M I Steinberg, K J Thrasher, et al.
JACS Au
|
March 27, 2026
Amine-to-Halogen Exchange Enables an Amine-Acid Etherification
Andrew McGrath, Sandip Kumar Das, Eunjae Shim, et al.
Pediatrics
|
May 3, 2006
Intussusception after administration of the rhesus tetravalent rotavirus vaccine (Rotashield): the search for a pathogenic mechanism
Maureen Lynch, Wun-Ju Shieh, Joseph S Bresee, et al.
Epidemiology and Infection
|
July 28, 2006
Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community
F Coronado, J A Nicholas, B J Wallace, et al.
Journal of Lipid Research
|
September 30, 2011
Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
Guoqing Cao, Thomas P Beyer, Youyan Zhang, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 11, 2012
Multiplex assay for species identification and monitoring of insecticide resistance in Anopheles punctulatus group populations of Papua New Guinea
Cara N Henry-Halldin, Kogulan Nadesakumaran, John Bosco Keven, et al.
Neuropharmacology
|
June 19, 2001
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro
P Miu, K R Jarvie, V Radhakrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2012
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma
Andrzej J Jakubowiak, Don M Benson, William Bensinger, et al.
The Senior Care Pharmacist
|
October 3, 2025
Medical Conditions and Medications Associated with Falls in Low-Income Community-Dwelling Older Adults
Emma Ager, Aundrea Jones, Alexandra Lewis, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 26, 2022
Quantitation of the next-generation imipridone ONC206 in human plasma by a simple and sensitive UPLC-MS/MS assay for clinical pharmacokinetic application
Jennifer C Goodell, Sara M Zimmerman, Cody J Peer, et al.
Page
of 92
Search research articles
Search
Showing results (821-830 of 915) with videos related to
Sort By:
Page
of 92
Journal of Medicinal Chemistry
|
December 23, 1994
Structural evolution and pharmacology of a novel series of triacid angiotensin II receptor antagonists
A D Palkowitz, M I Steinberg, K J Thrasher, et al.
JACS Au
|
March 27, 2026
Amine-to-Halogen Exchange Enables an Amine-Acid Etherification
Andrew McGrath, Sandip Kumar Das, Eunjae Shim, et al.
Pediatrics
|
May 3, 2006
Intussusception after administration of the rhesus tetravalent rotavirus vaccine (Rotashield): the search for a pathogenic mechanism
Maureen Lynch, Wun-Ju Shieh, Joseph S Bresee, et al.
Epidemiology and Infection
|
July 28, 2006
Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community
F Coronado, J A Nicholas, B J Wallace, et al.
Journal of Lipid Research
|
September 30, 2011
Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
Guoqing Cao, Thomas P Beyer, Youyan Zhang, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 11, 2012
Multiplex assay for species identification and monitoring of insecticide resistance in Anopheles punctulatus group populations of Papua New Guinea
Cara N Henry-Halldin, Kogulan Nadesakumaran, John Bosco Keven, et al.
Neuropharmacology
|
June 19, 2001
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro
P Miu, K R Jarvie, V Radhakrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2012
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma
Andrzej J Jakubowiak, Don M Benson, William Bensinger, et al.
The Senior Care Pharmacist
|
October 3, 2025
Medical Conditions and Medications Associated with Falls in Low-Income Community-Dwelling Older Adults
Emma Ager, Aundrea Jones, Alexandra Lewis, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 26, 2022
Quantitation of the next-generation imipridone ONC206 in human plasma by a simple and sensitive UPLC-MS/MS assay for clinical pharmacokinetic application
Jennifer C Goodell, Sara M Zimmerman, Cody J Peer, et al.
Page
of 92